Clinical Trial Update: A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of NT 201 injections versus placebo in adults with chronic peripheral neuropathic pain due to posthe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Nerve Injury
• Postherpetic Neuralgia

Drugs mentioned

• NT 201

Snippet

Sponsor: Merz Therapeutics GmbH | Conditions: Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury | Phase 2 | Status: COMPLETED